National Bank of Canada
IRWD icon

National Bank of Canada’s Ironwood Pharmaceuticals IRWD Stock Holding History

National Bank of Canada’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$155K Buy
+44,094
New +$181K ﹤0.01% 1683
2025
Q3 		– Sell
-1
Closed -$1 – 3036
2025
Q2 		$1 Hold
1
– – ﹤0.01% 2970
2025
Q1 		$1 Buy
+1
New +$2 ﹤0.01% 2824

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

National Bank of Canada's IRWD Position: Q1 2026 in Review

National Bank of Canada opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 44,094 shares worth $155K. The stake represents ﹤0.01% of the portfolio and ranks #1683 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in IRWD as recently as Q2 2025.

National Bank of Canada first reported a position in IRWD in Q1 2025 and has held it in 3 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • National Bank of Canada held 44,094 shares of Ironwood Pharmaceuticals worth $155K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new National Bank of Canada position in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #1683 holding.
  • National Bank of Canada first reported a position in Ironwood Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.